Search Orphan Drug Designations and Approvals
-
Generic Name: | Rifapentine | ||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Trade Name: | Priftin | ||||||||||||||||
Date Designated: | 06/09/1995 | ||||||||||||||||
Orphan Designation: | Treatment of pulmonary tuberculosis. | ||||||||||||||||
Orphan Designation Status: | Designated/Approved | ||||||||||||||||
Sponsor: |
Hoechst Marion Roussel P.O. Box 9627 Mail Station: H3-M2516 Kansas City, Missouri 64134 United States The sponsor address listed is the last reported by the sponsor to OOPD. |
||||||||||||||||
Marketing approved: |
|||||||||||||||||
1 | Generic Name: | Rifapentine |
---|---|---|
Trade Name: | Priftin | |
Marketing Approval Date: | 06/22/1998 | |
Approved Labeled Indication: | ||
Exclusivity End Date: | 06/22/2005 | |
Exclusivity Protected Indication* : | ||
*Data for the Date Designation Withdrawn or Revoked field are shown for designations withdrawn or revoked after 08/12/2013.
-